Lv2
120 积分 2026-03-04 加入
Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy
17天前
已完结
Abstract 6161: Exploring BRG399, a novel microtubule-binding agent, as an inducer of immunogenic cell death in cancer therapy
20天前
已关闭
Present and Future of Immunotherapy for Triple-Negative Breast Cancer
21天前
已完结
Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer
26天前
已完结
Peptidyl arginine deiminase 2 (PAD2) inhibition is associated with acute and long-term benefits in a murine model of traumatic brain injury
2个月前
已关闭
Fluorine-containing drugs approved by the US FDA in 2025
3个月前
已完结
Tumor‐Induced Splenic Remodeling: Mechanisms of Systemic Immunosuppression and Emerging Therapeutic Opportunities
3个月前
已完结
SHELXT– Integrated space-group and crystal-structure determination
4个月前
已完结
OLEX2: a complete structure solution, refinement and analysis program
4个月前
已完结
皖公网安备34019202002308
